文献速递关节外科

计算机导航与患者特异性器械对初次全膝关节置换术后翻修风险、患者报告结局及死亡率的影响:基于国家关节登记数据的分析

The Effects of Computer Navigation and Patient-Specific Instrumentation on Risk of Revision, PROMs, and Mortality Following Primary TKR: An Analysis of National Joint Registry Data.
PubMed 文献 · J Bone Joint Surg Am · 2025-02-19

该观察性研究利用国家关节登记数据,纳入2003年4月1日至2020年12月31日期间因骨关节炎行初次全膝关节置换的成年患者,比较计算机导航或患者特异性器械与传统器械在翻修、牛津膝关节评分、EQ-5D-3L及术后1年死亡率上的差异。结果显示,计算机导航和患者特异性器械对翻修风险、患者报告结局及死亡率均无统计学或临床意义上的影响。

要点

  • 计算机导航与传统器械相比,全因翻修风险无显著差异(HR 0.937,95%CI 0.860-1.021)。
  • 患者特异性器械与传统器械相比,全因翻修风险无显著差异(HR 0.960,95%CI 0.735-1.252)。
  • 计算机导航和患者特异性器械对术后6个月牛津膝关节评分、EQ-5D-3L及1年死亡率均无显著影响。

核心结论

  • 基于这项大型登记研究,作者认为计算机导航和患者特异性器械对初次全膝关节置换术后的翻修风险、患者报告结局或死亡率均无统计学或临床意义上的影响。

研究设计与样本

  • 观察性研究,使用国家关节登记数据,纳入2003年4月1日至2020年12月31日期间因骨关节炎行初次全膝关节置换的成年患者。
  • 采用倾向评分加权,并计算有效样本量以代表与未加权样本相当的统计效能。
  • 使用Cox比例风险模型评估翻修和死亡率结局,使用广义线性模型评估牛津膝关节评分和EQ-5D-3L的差异。

主要发现

  • 计算机导航组与传统器械组相比,全因翻修风险无显著差异(HR 0.937,95%CI 0.860-1.021;p=0.136;有效样本量91,607)。
  • 患者特异性器械组与传统器械组相比,全因翻修风险无显著差异(HR 0.960,95%CI 0.735-1.252;p=0.761;有效样本量13,297)。
  • 计算机导航与传统器械在牛津膝关节评分(-0.134,95%CI -0.331至0.063;p=0.183;有效样本量29,135)和EQ-5D-3L(0.000,95%CI -0.005至0.005;p=0.929;有效样本量28,396)上无差异。
  • 患者特异性器械与传统器械在牛津膝关节评分(0.363,95%CI -0.104至0.830;p=0.127;有效样本量4,412)和EQ-5D-3L(0.004,95%CI -0.009至0.018;p=0.511;有效样本量4,285)上无差异。
  • 传统器械与计算机导航或患者特异性器械相比,术后1年死亡率相似(HR 1.020,95%CI 0.989-1.052;p=0.212;有效样本量110,125)。

关键数值与推荐

  • 全因翻修:计算机导航组HR 0.937(95%CI 0.860-1.021;p=0.136;有效样本量91,607),患者特异性器械组HR 0.960(95%CI 0.735-1.252;p=0.761;有效样本量13,297),均以传统器械为参照。
  • 术后6个月牛津膝关节评分:计算机导航组与传统器械组差值-0.134(95%CI -0.331至0.063;p=0.183;有效样本量29,135);患者特异性器械组与传统器械组差值0.363(95%CI -0.104至0.830;p=0.127;有效样本量4,412)。
  • 术后6个月EQ-5D-3L:计算机导航组与传统器械组差值0.000(95%CI -0.005至0.005;p=0.929;有效样本量28,396);患者特异性器械组与传统器械组差值0.004(95%CI -0.009至0.018;p=0.511;有效样本量4,285)。
  • 术后1年死亡率:计算机导航或患者特异性器械与传统器械相比HR 1.020(95%CI 0.989-1.052;p=0.212;有效样本量110,125)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Computer navigation and patient-specific instrumentation have been in use over the past 2 decades for total knee replacement (TKR). However, their effects on implant survival and patient-reported outcomes remain under debate. We aimed to investigate their influence on implant survival, outcomes of the Oxford Knee Score (OKS) and health-related quality of life (EQ-5D-3L), intraoperative complications, and postoperative mortality compared with conventional instrumentation, across a real-world population. METHODS: This observational study used National Joint Registry (NJR) data and included adult patients who underwent primary TKR for osteoarthritis between April 1, 2003, and December 31, 2020. The primary analysis evaluated revision for all causes, and secondary analyses evaluated differences in the OKS and EQ-5D-3L at 6 months postoperatively, and mortality within 1 year postoperatively. Weights based on propensity scores were generated, accounting for several covariates. A Cox proportional hazards model was used to assess revision and mortality outcomes. Generalized linear models were used to evaluate differences in the OKS and EQ-5D-3L. Effective sample sizes were computed and represent the statistical power comparable with an unweighted sample. RESULTS: Compared to conventional instrumentation, the hazard ratios (HRs) for all-cause revision following TKR performed using computer navigation and patient-specific instrumentation were 0.937 (95% confidence interval [CI], 0.860 to 1.021; p = 0.136; effective sample size [ESS] = 91,607) and 0.960 (95% CI, 0.735 to 1.252; p = 0.761; ESS = 13,297), respectively. No differences were observed in the OKS and EQ-5D-3L between conventional and computer-navigated TKR (OKS, -0.134 [95% CI, -0.331 to 0.063]; p = 0.183; ESS = 29,135; and EQ-5D-3L, 0.000 [95% CI, -0.005 to 0.005]; p = 0.929; ESS = 28,396) and between conventional TKR and TKR with patient-specific instrumentation (OKS, 0.363 [95% CI, -0.104 to 0.830]; p = 0.127; ESS = 4,412; and EQ-5D-3L, 0.004 [95% CI, -0.009 to 0.018]; p = 0.511; ESS = 4,285). Mortality within 1 year postoperatively was similar between conventional instrumentation and either computer navigation or patient-specific instrumentation (HR, 1.020 [95% CI, 0.989 to 1.052]; p = 0.212; ESS = 110,125). CONCLUSIONS: On the basis of this large registry study, we conclude that computer navigation and patient-specific instrumentation have no statistically or clinically meaningful effect on the risk of revision, patient-reported outcomes, or mortality following primary TKR. LEVEL OF EVIDENCE: Therapeutic Level II . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Farhan-Alanie MM, Gallacher D, Craig P, et al. The Effects of Computer Navigation and Patient-Specific Instrumentation on Risk of Revision, PROMs, and Mortality Following Primary TKR: An Analysis of National Joint Registry Data. J Bone Joint Surg Am. 2025. PMID: 39970237. doi:10.2106/JBJS.24.00589

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。